ATE410521T1 - Ex-vivo-verfahren zur bestimmung der cetp- aktivität und der wirksamkeit der behandlung von herzerkrankungen - Google Patents
Ex-vivo-verfahren zur bestimmung der cetp- aktivität und der wirksamkeit der behandlung von herzerkrankungenInfo
- Publication number
- ATE410521T1 ATE410521T1 AT03724023T AT03724023T ATE410521T1 AT E410521 T1 ATE410521 T1 AT E410521T1 AT 03724023 T AT03724023 T AT 03724023T AT 03724023 T AT03724023 T AT 03724023T AT E410521 T1 ATE410521 T1 AT E410521T1
- Authority
- AT
- Austria
- Prior art keywords
- cetp activity
- heart disease
- vivo method
- treatment effectiveness
- determining
- Prior art date
Links
- KEWSCDNULKOKTG-UHFFFAOYSA-N 4-cyano-4-ethylsulfanylcarbothioylsulfanylpentanoic acid Chemical compound CCSC(=S)SC(C)(C#N)CCC(O)=O KEWSCDNULKOKTG-UHFFFAOYSA-N 0.000 title abstract 4
- 102100037637 Cholesteryl ester transfer protein Human genes 0.000 title abstract 4
- 101000880514 Homo sapiens Cholesteryl ester transfer protein Proteins 0.000 title abstract 4
- 208000019622 heart disease Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 abstract 2
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37262802P | 2002-04-11 | 2002-04-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410521T1 true ATE410521T1 (de) | 2008-10-15 |
Family
ID=29250882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03724023T ATE410521T1 (de) | 2002-04-11 | 2003-04-11 | Ex-vivo-verfahren zur bestimmung der cetp- aktivität und der wirksamkeit der behandlung von herzerkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7279297B2 (de) |
| EP (1) | EP1492880B1 (de) |
| JP (1) | JP4339702B2 (de) |
| AT (1) | ATE410521T1 (de) |
| AU (1) | AU2003230916A1 (de) |
| CA (1) | CA2480439C (de) |
| DE (1) | DE60323954D1 (de) |
| WO (1) | WO2003087396A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1444359A4 (de) * | 2001-10-23 | 2007-04-25 | Cardiovascular Targets Inc | Test für phospholipid-transferprotein-(pltp)-aktivität |
| WO2012074855A2 (en) * | 2010-11-22 | 2012-06-07 | The Regents Of The University Of California | Methods of identifying a cellular nascent rna transcript |
| US20130196340A1 (en) * | 2012-01-30 | 2013-08-01 | Roar Holding Llc | Ex vivo plasma enzyme activity assay using inhibitors as a negative control |
| CN107024590A (zh) * | 2017-03-13 | 2017-08-08 | 新疆医科大学 | 一种诊断1型和2型糖尿病的血清蛋白标志物组 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993011782A1 (en) * | 1991-12-19 | 1993-06-24 | Southwest Foundation For Biomedical Research | Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| US5585235A (en) * | 1993-04-13 | 1996-12-17 | Diagnescent Technologies, Inc. | Fluorescent assay and method that corrects for spectral interference |
| US5618683A (en) * | 1993-04-13 | 1997-04-08 | Brocia; Robert W. | Diagnostic kit for cholesteryl ester transfer protein (CETP) activity measurement and a new synthetic particle used therein |
| US6174693B1 (en) * | 1998-01-12 | 2001-01-16 | Robert W Brocia | Immunological assay for protein activity |
| HN2000000203A (es) * | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
-
2003
- 2003-04-11 DE DE60323954T patent/DE60323954D1/de not_active Expired - Lifetime
- 2003-04-11 JP JP2003584334A patent/JP4339702B2/ja not_active Expired - Fee Related
- 2003-04-11 CA CA2480439A patent/CA2480439C/en not_active Expired - Fee Related
- 2003-04-11 WO PCT/US2003/011443 patent/WO2003087396A1/en not_active Ceased
- 2003-04-11 EP EP03724023A patent/EP1492880B1/de not_active Expired - Lifetime
- 2003-04-11 US US10/413,419 patent/US7279297B2/en not_active Expired - Lifetime
- 2003-04-11 AT AT03724023T patent/ATE410521T1/de not_active IP Right Cessation
- 2003-04-11 AU AU2003230916A patent/AU2003230916A1/en not_active Abandoned
-
2007
- 2007-10-09 US US11/869,655 patent/US7642065B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003230916A1 (en) | 2003-10-27 |
| DE60323954D1 (de) | 2008-11-20 |
| EP1492880A1 (de) | 2005-01-05 |
| US7279297B2 (en) | 2007-10-09 |
| CA2480439A1 (en) | 2003-10-23 |
| EP1492880B1 (de) | 2008-10-08 |
| CA2480439C (en) | 2012-08-21 |
| JP4339702B2 (ja) | 2009-10-07 |
| JP2005522220A (ja) | 2005-07-28 |
| US7642065B2 (en) | 2010-01-05 |
| US20040018578A1 (en) | 2004-01-29 |
| US20080085530A1 (en) | 2008-04-10 |
| WO2003087396A1 (en) | 2003-10-23 |
| EP1492880A4 (de) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
| DE60329165D1 (de) | Detektion und/oder beobachtung von synuclein-assoziierten krankheiten | |
| DE60331892D1 (de) | Operationsinstrument und Verfahren zur Behandlung von Organvorfall | |
| DE60233485D1 (de) | Verfahren zur diagnose, behandlung und prävention von knochenverlust | |
| DE602004012079D1 (de) | Verwendung eines ibat-hemmers zur behandlung oder vorbeugung von verstopfung | |
| DE60324777D1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
| ATE369851T1 (de) | Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen | |
| DE59912716D1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
| ATE478062T1 (de) | Zusammensetzungen und verfahren zur in vivo abbildung von loeslichen beta-amyloid | |
| ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| DE602006010442D1 (de) | Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von schmerzen | |
| ATE275919T1 (de) | Verwendung von metall-proteinase-inhibitoren, um das wachstum der haare oder körperhaare zu induzieren und/oder zu stimulieren und/oder den haarausfall zu verlangsamen | |
| DE602004023721D1 (de) | Zusammensetzungen und methoden für die behandlung von herzerkrankungen | |
| ATE356995T1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| ATE171372T1 (de) | Verwendung eines antagonisten der substanz p zur behandlung von hautrötungen neurogen ursprungs | |
| ATE410521T1 (de) | Ex-vivo-verfahren zur bestimmung der cetp- aktivität und der wirksamkeit der behandlung von herzerkrankungen | |
| ATE380558T1 (de) | Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten | |
| ATE173620T1 (de) | Verwendung eines antagonisten von tnf-alpha zur behandlung von hautrötungen neurogenen ursprungs | |
| ATE383870T1 (de) | Behandlung von neurodegenerative krankheiten mit gpr49 | |
| EP4483880A4 (de) | Verwendung eines hpk1-inhibitors bei der behandlung von interferonbedingten erkrankungen | |
| DE50313393D1 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1 | |
| DE602006013604D1 (de) | Verfahren zur bestimmung der reaktionsfähigkeit gegenüber chk1-inhibitoren | |
| BRPI0515794A (pt) | processos para avaliar pacientes com leucemia mielóide aguda | |
| ATE404203T1 (de) | Verwendung von desoxypeganin zur behandlung der klinischen depression | |
| ATE438859T1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |